✦ LIBER ✦

Early results of intensified remission induction chemotherapy for childhood acute lymphocytic leukemia

✍ Scribed by Rivera, Gaston K. ;George, Stephen L. ;Williams, Dorothy ;Look, A. Thomas ;Abromowitch, Minnie ;Pui, Ching-Hon ;Ochs, Judith J. ;Dahl, Gary V. ;Kalwinsky, David K. ;Mirro, Joseph ;Dow, Lois W. ;Raimondi, Susana ;Murphy, Sharon B.

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 459 KB
Volume: 14
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950140313

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensive timed sequential remission ind

Intensive timed sequential remission induction chemotherapy with high-dose cytarabine for childhood acute myeloid leukemia

✍ Loeb, David M. ;Bowers, Daniel C. ;Civin, Curt I. ;Friedman, Alan D. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Background: Timed sequential chemotherapy and high-dose cytarabine (cytosine arabinoside, ara-c; hdac) are both effective treatments for acute myeloid leukemia (aml). we review our institutional experience with timed sequential induction chemotherapy consisting of daunorubicin/ara-c/-thioguanine

Failure of early intensive chemotherapy

Failure of early intensive chemotherapy to improve prognosis in childhood acute lymphocytic leukemia

✍ Camitta, Bruce M. ;Pinkel, Donald ;Thatcher, L. G. ;Casper, James ;Kun, Larry E. 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

## Abstract The ability of intensive therapy, early in remission, to improve prognosis in childhood acute lymphocytic leukemia was tested in a randomized study. The intensive treatment included cyclophosphamide (200 mg/m^2^ IV weekly × 4) and Adriamycin (40 mg/m^2^ IV weeks 1 and 3). These drugs we

A comparative study of central nervous s

A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia

✍ Rhomes J. A. Aur; Joseph V. Simone; H. Omar Hustu; Manuel S. Verzosa 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 974 KB

High-dose methotrexate for the remission

High-dose methotrexate for the remission induction of refractory adult acute lymphocytic leukemia

✍ Peterson, Bruce A. ;Bloomfield, Clara D. 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Six adults with refractory acute lymphocytic leukemia (ALL) were treated with high-dose methotrexate, citrovorum factor, and vincristine. All patients had previously received extensive treatment with standard therapeutic agents, including vincristine, and all but one had received prior methotrexate.

Combination chemotherapy for children wi

Combination chemotherapy for children with acute lymphocytic leukemia who fail to respond to standard remission-induction therapy

✍ H. N. Lay; Dr. H. Ekert; J. H. Colebatch 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB 👁 2 views

Selective use of daunorubicin for remiss

Selective use of daunorubicin for remission-induction chemotherapy in acute non-lymphoblastic leukemia

✍ B. S. Shaikh; J. B. Dougherty; R. W. Hamilton; J. O. Ballard; S. B. Patel; N. R. 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB 👁 2 views

Twenty-eight patients with acute non-lymphoblastic leukemia (ANLL) were started on induction chemotherapy consisting of Cytosine Arbinoside (Ara C) and 6 thioguanine (TG). Daunoruhicin (DNR) was used selectively in 20 of 28 patients who failed to respond by day 14 to the Ara C and TG combination. Se